Search
Patexia Research
Case number IPR2017-00827

Coherus BioSciences Inc. v. AbbVie Biotechnology Ltd. et al. > Documents

Date Field Doc. No.PartyDescription
Jun 5, 2017 13 Notice of Refund Download
May 25, 2017 12 PETITIONER'S REQUEST FOR REFUND OF POST-INSTITUTION FEES Download
Apr 11, 2017 11 Termination Decision Document Download
Apr 7, 2017 9 Petitioner's Unopposed Motion to Dismiss Petitions Without Prejudice Download
Apr 7, 2017 10 Order Conduct of the Proceeding Download
Mar 23, 2017 8 Petitioner's Updated Mandatory Notices Download
Mar 17, 2017 7 Patent Owner's Second Updated Mandatory Notices Download
Feb 27, 2017 6 Patent Owner's Updated Mandatory Notices Download
Feb 24, 2017 5 Notice of Accord Filing Date Download
Feb 21, 2017 4 Patent Owner's Mandatory Notices Download
Feb 21, 2017 3 Patent Owner's Power of Attorney Download
Jan 31, 2017 1265 Campath Label (Aug. 2006) Download
Jan 31, 2017 1236 Carnahan et al. 2003 Download
Jan 31, 2017 1282 Tsourounis (June 2005) Download
Jan 31, 2017 1273 van de Putte, et al. (September 1998) Download
Jan 31, 2017 1272 Dean, Lange's Handbook of Chemistry (9th ed. 1999) Download
Jan 31, 2017 1270 Note for Guidance on Development Pharmaceutics (Jan. 28, 1998) Download
Jan 31, 2017 1261 HepaGam B Summary Basis for Approval (Jan. 2006) Download
Jan 31, 2017 1271 Injection Tips (Archived Mar. 17, 2005) Download
Jan 31, 2017 1238 U.S. Pub. No. 2013/0273066 Download
Jan 31, 2017 1245 Granolleras et al. 1991 Download
Jan 31, 2017 1279 ENBREL Label (Sept. 2002) Download
Jan 31, 2017 1268 Hanna (Mar. 10, 2003) Download
Jan 31, 2017 1244 Schwartzman & Morgan 2004 Download
Jan 31, 2017 1249 A Bioworld Special Report: Biosimilars: U.S. Market Opportunities and Critical Strategies 2016 Download
Jan 31, 2017 1285 Nash (2016) Download
Jan 31, 2017 1248 Patent Owner's Preliminary Response, IPR2016-01018, Paper No. 9 Download
Jan 31, 2017 1257 OCTAGAM Label (Mar. 2004) Download
Jan 31, 2017 2 Petitioner's Signed Power of Attorney Download
Jan 31, 2017 1283 U.S. Patent No. 6,696,056, Cheung et al. Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download
Jan 31, 2017 1258 Flebogamma Label (Jan. 2004) Download
Jan 31, 2017 1240 U.S. Pub. No. 2008/0311078 Download
Jan 31, 2017 1278 Meadows & Hollowell (2008) Download
Jan 31, 2017 1231 Stoner et al. 2004 Download
Jan 31, 2017 1235 Gebhart 2001 Download
Jan 31, 2017 1281 REMICADE Label (Aug. 1998) Download
Jan 31, 2017 1234 U.S. Pub. No. 2004/0033535 Download
Jan 31, 2017 1277 HUMIRA Label (Nov. 2006) Download
Jan 31, 2017 1253 SYNAGIS Label (July 2004) Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download
Jan 31, 2017 1269 Handbook of Pharmaceutical Excipients (5th ed. 2006) Download
Jan 31, 2017 1280 ENBREL Label (Nov. 1998) Download
Jan 31, 2017 1250 WO 1997/029131, Salfeld et al. Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download
Jan 31, 2017 1252 HUMIRA Label (Oct. 2016) Download
Jan 31, 2017 1237 Press Release (Jan. 23, 2003) Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download
Jan 31, 2017 1274 HUMIRA Label (Oct. 2005) Download
Jan 31, 2017 1284 Summary Review for Regulatory Action, Sarah Yim, Division of Pulmonary, Allergy, and Rheumatology Products (U.S. FDA), of Humira (2015) Download
Jan 31, 2017 1276 HUMIRA Label (Feb. 2007) Download
Jan 31, 2017 1241 WO 2006/138181, Gokarn et al. Download
Jan 31, 2017 1242 U.S. Patent No. 6,090,382, Salfeld et al. Download
Jan 31, 2017 1255 CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) Download
Jan 31, 2017 1247 Clinical Pharmacology and Biopharmaceutics Review(s), Application No. 125057/0, in Approval Package for Humira (Approved Dec. 31, 2002) Download
Jan 31, 2017 1233 Schwartz 2003 Download
Jan 31, 2017 1230 U.S. Prosecution History of App. No. 61/004,992 Download
Jan 31, 2017 1263 TYSABRI Label (Nov. 2004) Download
Jan 31, 2017 1264 Vectibix Label (Sept. 2006) Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 Download
Jan 31, 2017 1232 Fraunhofer Substantive Motion 3, Patent Interference No. 106,057 Download
Jan 31, 2017 1256 GAMMAGARD LIQUID Label (April 2005) Download
Jan 31, 2017 1246 Development Pharmaceutics for Biotechnological and Biological Products (Oct. 21, 1999) Download
Jan 31, 2017 1239 U.S. Pub. No. 2012/0028877 Download
Jan 31, 2017 1260 Privigen Label (Oct. 2016) Download
Jan 31, 2017 1259 GAMUNEX Label (Nov. 2005) Download
Jan 31, 2017 1251 HUMIRA Label (Nov. 2015) Download
Jan 31, 2017 1275 HUMIRA Label (Feb. 2008) Download
Jan 31, 2017 1266 Akers et al. 2002 Download
Jan 31, 2017 1254 Vivaglobin Label (Jan. 2006) Download
Jan 31, 2017 1262 AVASTIN Label (Feb. 2004) Download
Jan 31, 2017 1243 Gottlieb 2005 Download
Jan 31, 2017 1267 Cleland & Langer 1994 Download
Jan 31, 2017 1224 Olthuis et al. 1994 Download
Jan 31, 2017 1202 Declaration of Klaus-Peter Radtke, Ph.D. Download
Jan 31, 2017 1222 Frenken et al. 1993 Download
Jan 31, 2017 1205 HUMIRA Label (Jan. 2003) Download
Jan 31, 2017 1221 Laursen et al. 2006 Download
Jan 31, 2017 1209 AbbVie Biotechnology Ltd., Annex A - The Humira Story Download
Jan 31, 2017 1204 U.S. App. 60/690,582 Download
Jan 31, 2017 1216 Van Slyke 1922 Download
Jan 31, 2017 1218 Gelfand 2006 Download
Jan 31, 2017 1228 U.S. Prosecution History of App. No. 13/774,735 - PART 1 of 2 Download
Jan 31, 2017 1207 Declaration of David D. Sherry, M.D. Download
Jan 31, 2017 1213 Jefferis et al. 1995 Download
Jan 31, 2017 1215 Christensen 1966 Download
Jan 31, 2017 1219 Fransson & Espander-Jansson 1996 Download
Jan 31, 2017 1227 U.S. Prosecution History of App. No. 14/506,576 Download
Jan 31, 2017 1228 U.S. Prosecution History of App. No. 13/774,735 - PART 1 of 2 Download
Jan 31, 2017 1220 U.S. Pub. No. 2003/0138417 Download
Jan 31, 2017 1 PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. 311-319 AND 37 C.F.R. 42 Download
Jan 31, 2017 1212 Butler & Hamilton 1991 Download
Jan 31, 2017 1217 Gokarn et al. 2006 Download
Jan 31, 2017 1201 U.S. Patent No. 9,085,619 Download
Jan 31, 2017 1210 U.S. Pub. No. 2003/0206898 Download
Jan 31, 2017 1208 Adalimumab Product Approval Information Download
Jan 31, 2017 1211 Parslow 1997 Download
Jan 31, 2017 1203 U.S. Pub. No. 2016/0319011 Download
Jan 31, 2017 1214 McDonnell 2015 Download
Jan 31, 2017 1206 HUMIRA Label (Jan. 2008) Download
Jan 31, 2017 1223 Nozaki & Tanford 1967 Download
Jan 31, 2017 1225 GAMIMUNE Label (Oct. 2005) Download
Jan 31, 2017 1226 Physicians Desk Reference (56th ed. 2002) Download
Jan 31, 2017 1228 U.S. Prosecution History of App. No. 13/774,735 - PART 2 of 2 Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 3 of 6 Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 4 of 6 Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 6 of 6 Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 1 of 6 Download
Jan 31, 2017 1229 U.S. Prosecution History of App. No. 12/325,049 - PART 2 of 6 Download
Menu